Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q96CV9: Variant p.Thr357Pro

Optineurin
Gene: OPTN
Feedback?
Variant information Variant position: help 357 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Threonine (T) to Proline (P) at position 357 (T357P, p.Thr357Pro). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (T) to medium size and hydrophobic (P) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page



Sequence information Variant position: help 357 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 577 The length of the canonical sequence.
Location on the sequence: help LERKNSAIPSELNEKQELVY T NKKLELQVESMLSEIKMEQA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         LERKNSAIPSELNEKQELVYTNKKLELQVESMLSEIKMEQA

Rhesus macaque                LERKNSATPSELNEKQELVYTNKKLELQVESMLSEIKMEQA

Mouse                         LERKNSATPSELNEKQELVYSNKKLELQVESMRSEIKMEQA

Rat                           LERKNSATPSELNEKQELVYSNRKLELQVESMRSEIKMEQA

Pig                           LERKNSATPSELNEKQELLYNNKKLELQVESMRSEIKMEQA

Chicken                       LEKVNSAAATELEEKQQLIYTIKKLELQVESVQAEVKLEQA

Xenopus laevis                LDKRLQENQVDLEEKQSLRYSIKKLELQVESQESEIKLEQN

Zebrafish                     LEQDLGTLKTQLGDKQKVQAENDCLKVQMESLQAAIKLEQK

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 577 Optineurin
Coiled coil 239 – 508
Modified residue 342 – 342 Phosphoserine



Literature citations
Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains.
Li Y.; Kang J.; Horwitz M.S.;
Mol. Cell. Biol. 18:1601-1610(1998)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 3); VARIANTS SER-201; HIS-213; ARG-216 AND PRO-357; SUBCELLULAR LOCATION; TISSUE SPECIFICITY; INDUCTION BY TNF; INTERACTION WITH ADENOVIRUS E3; Adult-onset primary open-angle glaucoma caused by mutations in optineurin.
Rezaie T.; Child A.; Hitchings R.; Brice G.; Miller L.; Coca-Prados M.; Heon E.; Krupin T.; Ritch R.; Kreutzer D.; Crick R.P.; Sarfarazi M.;
Science 295:1077-1079(2002)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); FUNCTION; SUBCELLULAR LOCATION; TISSUE SPECIFICITY; VARIANTS GLC1E LYS-50 AND GLN-545; VARIANTS LYS-98; SER-201; HIS-213; ARG-216 AND PRO-357; Human FIP-2: genomic structure and mutational analysis in ARVD patients.
Li D.; Roberts R.;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS SER-201; HIS-213; ARG-216 AND PRO-357;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.